Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (Weighted Average) (2021 - 2026)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Shares Outstanding (Weighted Average) of $5.0 million in Q1 2026, up 207.19% quarter-over-quarter from $1.6 million in Q4 2025, and up 1151.77% on a YoY basis from $401957.0 in Q1 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $5.0 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 1151.77% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (up 1151.77% YoY), while the FY2025 annual figure was $1.6 million, down 42.93% from the prior year.
  • Shares Outstanding (Weighted Average) was $5.0 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $9.7 million in Q3 2022 to a low of $83636.0 in Q2 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $2.8 million across 5 years, with a median of $1.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) surged 10923.83% in 2022, then sank 95.56% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 million in 2022, then soared by 39.51% to $1.9 million in 2023, then slumped by 93.85% to $114807.0 in 2024, then jumped by 1326.68% to $1.6 million in 2025, then surged by 207.19% to $5.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $5.0 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Shuttle Pharmaceuticals Holdings 2.17 Mn 1.11 Mn - 5.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.03 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 1.26 Mn
Jun 30, 2025 766,021.00
Mar 31, 2025 401,957.00
Dec 31, 2024 114,807.00
Sep 30, 2024 87,439.00
Jun 30, 2024 83,636.00
Mar 31, 2024 2.08 Mn
Dec 31, 2023 1.87 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.74 Mn
Mar 31, 2023 1.70 Mn
Dec 31, 2022 1.34 Mn
Sep 30, 2022 9.72 Mn
Jun 30, 2022 9.29 Mn
Mar 31, 2022 9.31 Mn
Dec 31, 2021 12,135.00
Sep 30, 2021 9.30 Mn